Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure

American Journal of Cardiology - Tập 84 - Trang 1038-1043 - 1999
Marco Guazzi1, Pietro Palermo1, Gianluca Pontone1, Francesca Susini1, Piergiuseppe Agostoni1
1Istituto di Cardiologia dell’Università degli Studi, Centro di Studio per le Ricerche Cardiovascolari del Consiglio Nazionale delle Ricerche, Fondazione “Monzino,” I.R.C.C.S., Milan, Italy

Tài liệu tham khảo

Mancini, 1991, Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure, Circulation, 83, 778, 10.1161/01.CIR.83.3.778

Wasserman, 1997, Diagnosing cardiovascular and lung pathophysiology from exercise gas exchange, Chest, 112, 1091, 10.1378/chest.112.4.1091

Drexler, 1998, Endothelium as a therapeutic target in heart failure, Circulation, 98, 2652, 10.1161/01.CIR.98.24.2652

Guazzi, 1997, Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin, Circulation, 95, 1930, 10.1161/01.CIR.95.7.1930

Guazzi, 1999, Aspirin worsens exercise performance and pulmonary gas exchange in heart failure patients who are taking ACE-inhibitors, Am Heart J, 138, 254, 10.1016/S0002-8703(99)70109-2

Spinale, 1997, Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure. I. Effects on left ventricular performance and neurohumoral systems, Circulation, 96, 2385, 10.1161/01.CIR.96.7.2385

Azizi, 1995, Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium depleted normotensives, Circulation, 92, 825, 10.1161/01.CIR.92.4.825

Hamroff, 1997, Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure, J Cardiovasc Pharmacol, 30, 533, 10.1097/00005344-199710000-00020

Roughton, 1957, Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in human lung, with special reference to true diffusing capacity of blood in the lung capillaries, J Appl Physiol, 11, 290, 10.1152/jappl.1957.11.2.290

Cotes, 1972, Iron deficiency anemia, Clin Sci, 42, 325, 10.1042/cs0420325

Myers, 1990, Optimizing the exercise test for pharmacological investigations, Circulation, 82, 1839, 10.1161/01.CIR.82.5.1839

Wasserman, 1994, Coupling of external to cellular respiration during exercise, Am J Physiol, 266, E519

Rector, 1993, Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo, Am J Cardiol, 71, 1106, 10.1016/0002-9149(93)90582-W

Weber, 1985, Cardiopulmonary exercise testing for evaluation of chronic cardiac failure, Am J Cardiol, 55, 22A, 10.1016/0002-9149(85)90792-1

Chua, 1997, Clinical correlates and prognostic significance of the ventilatory response in chronic heart failure, J Am Coll Cardiol, 29, 1585, 10.1016/S0735-1097(97)00078-8

Lang, 1997, Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure, J Am Coll Cardiol, 30, 983, 10.1016/S0735-1097(97)00253-2

Guazzi, 1997, Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, Am J Cardiol, 80, 1572, 10.1016/S0002-9149(97)00781-9

Vescovo, 1998, Improved exercise tolerance after losartan and enalapril in heart failure. Correlation with changes in skeletal muscle heavy chain composition, Circulation, 98, 1742, 10.1161/01.CIR.98.17.1742

Guazzi, 1999, ACE-inhibition restores the diffusing capacity to carbon monoxide in chronic heart failure patients by improving the molecular diffusion across the alveolar-capillary membrane, Clin Sci, 96, 17, 10.1042/cs0960017

Wasserman, 1997, Lung function and exercise gas exchange in chronic heart failure, Circulation, 96, 2221, 10.1161/01.CIR.96.7.2221

Hollenberg, 1998, Pathways for angiotensin II generation in intact human tissue. Evidence from comparative pharmacological interruption of the renin system, Hypertension, 32, 387, 10.1161/01.HYP.32.3.387

Drexler, 1989, Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind placebo-controlled trial, Circulation, 79, 491, 10.1161/01.CIR.79.3.491

Hornig, 1998, Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure, Circulation, 98, 2842, 10.1161/01.CIR.98.25.2842

Pitt, 1997, Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan In The Elderly Study, ELITE), Lancet, 349, 747, 10.1016/S0140-6736(97)01187-2

Guazzi, 1999, ACE-inhibition facilitates alveolar-capillary gas transfer, and improves ventilation/perfusion coupling in patients with left ventricular dysfunction, Clin Pharmacol Therap, 65, 319, 10.1016/S0009-9236(99)70111-6